Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study

OBJECTIVE: Some previous studies have found clinical benefit of dual antiplatelet therapy with aspirin and cilostazol for prevention of secondary stroke, but the physiological mechanism involved remains unknown. We aimed to clarify the effects of aspirin/cilostazol therapy on the platelet and endoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnuki, Yoichi, Ohnuki, Yuko, Kohara, Saori, Shimizu, Mie, Takizawa, Shunya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498192/
https://www.ncbi.nlm.nih.gov/pubmed/28566591
http://dx.doi.org/10.2169/internalmedicine.56.7760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498192/
https://www.ncbi.nlm.nih.gov/pubmed/28566591
http://dx.doi.org/10.2169/internalmedicine.56.7760

Ejemplares similares